Picture of Avadel Pharmaceuticals logo

AVDL — Avadel Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Avadel Pharmaceuticals PLC reports results for the quarter ended in June - Earnings Summary

* Avadel Pharmaceuticals PLC  AVDL.OQ  reported a quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of -83 cents.  The mean expectation of ten analysts
for the quarter was for a loss of 16 cents per share. Wall
Street expected results to range from -21 cents to -1 cents per
share.
    * Revenue rose 2,674.3% to $41.50 million from a year ago;
analysts expected $37.53 million. 
    * Avadel Pharmaceuticals PLC's reported EPS for the quarter
was a
loss of 14 cents​.
    * The company reported a quarterly loss of $13.82 million.
    * Avadel Pharmaceuticals PLC shares had risen by 14.5% this
quarter and gained 14.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.3%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Avadel
Pharmaceuticals PLC is $23.00 
This summary was machine generated from LSEG data August 8 at
03:28 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.16          -0.14          Beat
 Mar. 31 2024      -0.21          -0.30          Missed
 Dec. 31 2023      -0.26          -0.29          Missed
 Sep. 30 2023      -0.37          -0.41          Missed

Recent news on Avadel Pharmaceuticals

See all news